Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Mov Disord Clin Pract ; 6(2): 166-170, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30838317

ABSTRACT

BACKGROUND: A heterozygous mutation in the TOR1A gene (DYT1) accounts for isolated dystonia typically presenting during childhood or adolescence, with initial involvement of one limb, spreading rapidly to other limbs and the trunk, sparing craniocervical muscles. However, atypical phenotypes, regarding age at onset, site of presentation, and spreading have been reported. METHODS AND FINDINGS: In 2006, we described a large Italian family showing atypical phenotypes and intrafamilial clinical variability of DYT1-dystonia. The current article reports on a 12-year follow-up of this family, focusing on disease onset in three previously asymptomatic DYT1 mutation carriers, and the reassessment of initially affected individuals. CONCLUSIONS: The new cases confirm the intrafamilial phenotypic heterogeneity of DYT1-dystonia. Moreover, this case series highlights that symptoms in atypical phenotypes seem not to spread significantly and in the long term, rarely worsen. Prolonged follow-up of DYT1-positive pedigrees may expand the clinical spectrum of DYT1-dystonia.

2.
J Neurol Sci ; 288(1-2): 68-71, 2010 Jan 15.
Article in English | MEDLINE | ID: mdl-19896680

ABSTRACT

Post-streptococcal neuropsychiatric disorders encompass a broad spectrum of movement disorders, including tics, stereotypies, dystonia and tremor. We report the case of a 15-year-old boy who presented with a relapsing-remitting combination of psychogenic and organic movement disorders. Both relapses occurred after an episode of streptococcal pharyngitis and consisted in motor and phonic tics, an atypical gait disorder, and severe worsening of a pre-existing psychogenic tremor of the right hand. After each relapse, both psychogenic and 'organic' symptoms concomitantly remitted after the administration of an association of oral steroids and antibiotics. The peculiarity of this case consists in the coexistence of psychogenic and organic symptoms subsequent to streptococcal infection, and broadens the clinical spectrum of post-streptococcal neuropsychiatric disorders.


Subject(s)
Autoimmune Diseases of the Nervous System/pathology , Autoimmune Diseases of the Nervous System/psychology , Mental Disorders/pathology , Mental Disorders/psychology , Movement Disorders/pathology , Movement Disorders/psychology , Streptococcal Infections/pathology , Streptococcal Infections/psychology , Adolescent , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Autoimmune Diseases of the Nervous System/microbiology , Electromyography , Gait Disorders, Neurologic/etiology , Gait Disorders, Neurologic/physiopathology , Humans , Male , Mental Disorders/etiology , Movement Disorders/etiology , Muscle, Skeletal/physiopathology , Pharyngitis/complications , Pharyngitis/microbiology , Recurrence , Streptococcal Infections/microbiology , Tics/etiology , Tremor/etiology , Tremor/physiopathology
3.
J Neurol ; 255(9): 1372-7, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18584234

ABSTRACT

BACKGROUND: Mutations in the PINK1 gene, encoding a mitochondrial protein kinase, represent the second cause of autosomal recessive parkinsonism (ARP) after Parkin. While homozygous or compound heterozygous mutations in these genes are unequivocally causative of ARP, the role of single heterozygous mutations is still largely debated. An intriguing hypothesis suggests that these mutations could represent a risk factor to develop parkinsonism, by contributing to nigral cell degeneration. Since the substantia nigra plays an important role in temporal processing of sensory stimuli, as revealed from studies in idiopathic PD, we sought to investigate whether any subclinical sensory abnormalities could be detected in patients with PINK1- related parkinsonism and in unaffected PINK1 heterozygous carriers. METHODS: We adopted a psychophysical method, the temporal discrimination paradigm, to assess PINK1 homozygous patients, unaffected relatives who were heterozygous carriers of the same mutations and healthy control subjects. Temporal discrimination threshold (TDT) and temporal order judgement (TOJ) for pairs of tactile, visual or visuo-tactile stimuli were measured according to a standardized protocol. FINDINGS: Higher mean tactile and visuo-tactile TDTs and TOJs were detected in PINK1 mutation carriers, including not only homozygous patients but also healthy heterozygotes, compared to control subjects (for all comparisons, p < 0.001). INTERPRETATION: In clinically unaffected subjects, the mere presence of a heterozygous PINK1 mutation is sufficient to determine sensory alterations which can be disclosed by a psychophysical task. Deficits in temporal processing might be considered as subclinical signs of alteration at least in PINK1-related parkinsonism.


Subject(s)
Heterozygote , Parkinsonian Disorders/genetics , Parkinsonian Disorders/physiopathology , Protein Kinases/genetics , Psychomotor Performance/physiology , Adult , Aged , Aged, 80 and over , Discrimination, Psychological/physiology , Electric Stimulation/methods , Female , Genes, Recessive , Genetic Predisposition to Disease , Homozygote , Humans , Male , Middle Aged , Mutation , Neuropsychological Tests , Parkinsonian Disorders/psychology , Photic Stimulation/methods , Reaction Time/physiology , Sensory Thresholds/physiology , Touch Perception/physiology , Visual Perception/physiology , Young Adult
4.
Stroke ; 38(3): 1088-90, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17255546

ABSTRACT

BACKGROUND AND PURPOSE: Early prognosis of arm recovery is a major clinical issue in stroke. The aim of this study was to assess the prognostic value of 4 simple bedside tests. METHODS: Forty-eight patients with arm paresis/plegia were evaluated on days 7, 14, 30, 90 and 180 after stroke. Assessment included 4 potential predictors of arm recovery (active finger extension, shoulder abduction, shoulder shrug and hand movement scales) and 3 outcome measures evaluating arm function (Nine Hole Peg Test, Fugl-Meyer arm subtest, Motricity Index arm subtest). RESULTS: The active finger extension scale was the most powerful prognostic factor. Patients with active finger extension scores >3 had a high probability of achieving good performance as assessed by the Motricity Index. CONCLUSIONS: Active finger extension is a reliable early predictor of recovery of arm function in stroke patients.


Subject(s)
Fingers/physiology , Movement/physiology , Recovery of Function/physiology , Stroke/physiopathology , Acute Disease , Aged , Aged, 80 and over , Arm/physiology , Female , Hand Strength/physiology , Humans , Male , Paresis/physiopathology , Paresis/rehabilitation , Predictive Value of Tests , Prospective Studies , Stroke Rehabilitation
5.
Brain ; 130(Pt 1): 134-42, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17105745

ABSTRACT

DYT1 primary torsion dystonia is an autosomal dominant movement disorder due to a 3-bp GAG deletion in the TOR1A gene, which becomes manifest in only 30-40% of mutation carriers. Investigating the factors regulating this reduced penetrance might add new insight into the mechanisms underlying the disease. The pathophysiology of dystonia has been related to basal ganglia dysfunctions that lead to the most prominent motor symptoms. However, subclinical sensory deficits have also been reported, particularly in adult-onset focal dystonia. Sensory abnormalities in different forms of sporadic dystonia have been revealed by using a psychophysical method, namely, the temporal discrimination threshold (TDT), quantified as the shortest time interval at which the two stimuli are perceived as separate. Little or no information about the presence of sensory abnormalities in DYT1 gene manifesting and non-manifesting carriers is available. With the aim of disclosing possible associations between sensory deficits and the DYT1 mutation, we assessed TDTs of DYT1 manifesting patients (n = 9); DYT1 non-manifesting relatives (n = 11); non-carrier relatives (n = 9); external control subjects (n = 11). Pairs of tactile, visual or visuo-tactile stimuli were delivered in blocked, counterbalanced order. Intervals between stimuli increased from 0 to 400 ms (in 10 ms steps). On each trial, subjects had to report whether stimuli occurred simultaneously or asynchronously. We measured the first out of three consecutive inter-stimulus intervals at which subjects recognized the two stimuli as temporally separated (TDT) and the first of three consecutive intervals at which they also reported correctly which stimulus in the pair preceded (or followed) the other temporal order judgment (TOJ). Results showed higher tactile and visuo-tactile TDTs and TOJs in DYT1 carriers, both manifesting and non-manifesting, compared with non-carrier relatives and with external control subjects (for all comparisons, P < 0.039). This finding indicates that the DYT1 mutation determines subclinical sensory alterations, which could be disclosed by a psychophysical task. Moreover, these results have the notable implication that sensory deficits in dystonia are not a mere consequence of abnormal movements, but they may even occur before overt clinical manifestations, representing a subclinical phenotype in DYT1 mutation carriers.


Subject(s)
Dystonia Musculorum Deformans/genetics , Molecular Chaperones/genetics , Sensation Disorders/genetics , Adult , Aged , Discrimination, Psychological , Dystonia Musculorum Deformans/complications , Dystonia Musculorum Deformans/physiopathology , Family Health , Female , Heterozygote , Humans , Judgment , Male , Middle Aged , Mutation/genetics , Phenotype , Psychophysics , Sensation Disorders/complications , Sensation Disorders/physiopathology , Sensory Thresholds/physiology , Time Factors , Touch/physiology , Vision Disorders/complications , Vision Disorders/genetics , Vision Disorders/physiopathology
6.
Mov Disord ; 21(10): 1782-4, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16874761

ABSTRACT

The GAG deletion in the DYT1 gene usually causes a typical form of primary torsion dystonia (PTD) with early onset in a limb, rapid generalization, and sparing of cranial-cervical muscles, but atypical phenotypes have often been reported. Here, we describe a large DYT1 Italian family with phenotypically heterogeneous PTD that recapitulates all the atypical features associated with the DYT1 mutation, including late age at onset, focal or segmental phenotypes, onset or spreading of dystonia to the cranial-cervical muscles. Of 38 healthy family members, 15 also carried the DYT1 mutation, with an estimated penetrance of 21%. A literature review of atypical familial cases of DYT1-PTD showed that late onset, cervical involvement, and limited progression of dystonia are features frequently seen in DYT1 families. However, nearly all of these atypical patients fall within at least one of the clinical categories that best predict the DYT1 carrier status, namely, early onset, onset in a limb, and family history positive for early-onset dystonia.


Subject(s)
Dystonia Musculorum Deformans/genetics , Dystonia/genetics , Molecular Chaperones/genetics , Phenotype , Adult , Aged , Chromosome Deletion , Dystonia/diagnosis , Dystonia Musculorum Deformans/diagnosis , Female , Genetic Carrier Screening , Humans , Italy , Male , Middle Aged , Neurologic Examination , Pedigree , Penetrance , Trinucleotide Repeats/genetics
7.
Mov Disord ; 21(2): 270-3, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16161148

ABSTRACT

We report on a patient affected by Parkinson's disease who developed over a period of a few weeks a tonic deviation of her head, neck, and trunk fitting the typical description of Pisa syndrome (PS). This patient was under stable levodopa and pramipexole treatment and had never been exposed to any psychotropic or antiemetic drugs before or at the time she developed the postural abnormality. Because dopamine transporter imaging revealed bilateral and symmetrical reduction of striatal uptake, we suggest that PS is not primarily related to side differences in dopaminergic denervation or drug exposure.


Subject(s)
Antiparkinson Agents/administration & dosage , Antipsychotic Agents/administration & dosage , Dystonia Musculorum Deformans/diagnosis , Levodopa/administration & dosage , Parkinson Disease/diagnosis , Aged , Antiparkinson Agents/adverse effects , Cerebral Cortex/physiopathology , Corpus Striatum/physiopathology , Dopamine Plasma Membrane Transport Proteins/physiology , Dose-Response Relationship, Drug , Drug Administration Schedule , Dystonia Musculorum Deformans/physiopathology , Female , Humans , Levodopa/adverse effects , Parkinson Disease/drug therapy , Parkinson Disease/physiopathology , Syndrome , Tomography, Emission-Computed, Single-Photon
SELECTION OF CITATIONS
SEARCH DETAIL
...